Inclusion of diversity can impact design, recruitment, informed consent and data in clinical trials. Listen as rheumatologist Dr. Niti Goel, Duke University School of Medicine, Durham, NC, addresses issues tied to diversity and what can be done to improve inclusion in clinical trials. For disclosures and to claim credit go to https://www.eeds.com/em/1732. This program is supported by an unrestricted educational grant from Amgen.